These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 2198216

  • 1. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
    Ertl G, Gaudron P, Eilles C.
    Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 3. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [Abstract] [Full Text] [Related]

  • 4. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995 Feb; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 5. [The value of ACE inhibitors in heart failure (mechanism of action)].
    Drexler H.
    Z Kardiol; 1992 Feb; 81 Suppl 4():85-91. PubMed ID: 1290308
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB.
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [Abstract] [Full Text] [Related]

  • 7. Treatment of hypertensive heart disease with ACE inhibitors.
    Stumpe KO.
    J Cardiovasc Pharmacol; 1987 Aug; 10 Suppl 6():S166-71. PubMed ID: 2485024
    [Abstract] [Full Text] [Related]

  • 8. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M, Gohlke P, Paul M, Stoll M, Unger T.
    J Cardiovasc Pharmacol; 1994 Aug; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [Abstract] [Full Text] [Related]

  • 9. [Indications for ACE inhibitors in chronic heart failure].
    Erdmann E.
    Z Kardiol; 1994 Aug; 83 Suppl 4():75-9. PubMed ID: 7856285
    [Abstract] [Full Text] [Related]

  • 10. [Converting enzyme inhibitors and coronary failure].
    Castaigne A, Saal JP, Albo C, Verschuren P, Pham I.
    Rev Prat; 1992 Dec 15; 42(20):2568-73. PubMed ID: 1299942
    [Abstract] [Full Text] [Related]

  • 11. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D.
    Acta Med Croatica; 2004 Dec 15; 58(2):129-34. PubMed ID: 15208798
    [Abstract] [Full Text] [Related]

  • 12. [ACE inhibitors in the treatment of patients after myocardial infarct].
    Widimský J.
    Vnitr Lek; 1993 Jun 15; 39(6):527-35. PubMed ID: 8212605
    [Abstract] [Full Text] [Related]

  • 13. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
    Banerjee A, Talreja A, Sonnenblick EH, LeJemtel TH.
    Mt Sinai J Med; 2003 Sep 15; 70(4):225-31. PubMed ID: 12968195
    [Abstract] [Full Text] [Related]

  • 14. [Indications for ACE inhibitors in the postinfarct period].
    Ertl G, Gaudron P, Neubauer S, Hu K, Zdrojewski T, Horn M, Kochsiek K.
    Z Kardiol; 1994 Sep 15; 83 Suppl 4():65-74. PubMed ID: 7856283
    [Abstract] [Full Text] [Related]

  • 15. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M.
    Heart Lung; 1990 Sep 15; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitors in heart failure: a role after myocardial infarction.
    Sharpe N.
    J Cardiovasc Pharmacol; 1991 Sep 15; 18 Suppl 2():S99-104. PubMed ID: 1725054
    [Abstract] [Full Text] [Related]

  • 17. The current status of angiotensin converting enzyme inhibitors in the management of patients with chronic heart failure.
    Packer M, Kukin ML, Neuberg GW, Pinsky DJ, Penn J, Abittan MH.
    J Hypertens Suppl; 1989 Sep 15; 7(5):S33-6. PubMed ID: 2681605
    [Abstract] [Full Text] [Related]

  • 18. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W, Eber B, Gasser R, Stoschitzky K, Schumacher M, Fruhwald FM, Zweiker R.
    Wien Med Wochenschr; 1996 Sep 15; 146(11):221-4. PubMed ID: 8928518
    [Abstract] [Full Text] [Related]

  • 19. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD.
    J Cardiovasc Pharmacol; 1994 Sep 15; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [Abstract] [Full Text] [Related]

  • 20. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB, Davies RO, Ferguson RK.
    Fed Proc; 1984 Apr 15; 43(5):1314-21. PubMed ID: 6323221
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.